Denali Therapeutics DNLI
NASDAQ DNLI
$20.69 +0.02 (+0.12%)
As of: Oct 1, 2026 · 10:24 AM EDT

Denali Therapeutics (DNLI) Shares Outstanding (2017 - 2026)

Updated

Denali Therapeutics (DNLI) reported Shares Outstanding of 187.31 million for Q2 2026, up 9.3% from 171.45 million a year earlier and up 0.4% from the prior quarter.

Analysis

Denali Therapeutics (DNLI) Shares Outstanding (2017 - 2026) Analysis & Trends

For FY2025, Denali Therapeutics posted Shares Outstanding of 172.65 million, up 5.0% from FY2024.

  • Shares Outstanding has increased for nine consecutive years, with a five-year compound annual growth rate of 9.6% (FY2020 to FY2025).
  • By year, Shares Outstanding came in at 164.47 million in FY2024 (+19.7%), 137.37 million in FY2023 (+9.4%), 125.53 million in FY2022 (+3.3%) and 121.52 million in FY2021 (+11.5%).
  • The Q2 2026 figure ranks as the highest quarterly Shares Outstanding in data going back to Q1 2017.
  • Year over year, Shares Outstanding has now increased in each of the last 34 quarters, with growth averaging 10.5% over the last eight quarters.
  • Across the past five years, year-over-year growth in Shares Outstanding ran from 1.4% in Q2 2022 to 23.2% in Q2 2024.
  • Per Business Quant data, the three quarters before Q2 2026 came in at 186.64 million (Q1 2026), 172.65 million (Q4 2025) and 172.42 million (Q3 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Shares Outstanding (Qtr)
1 Johnson & Johnson 638.12 Bn 556.64 Bn 17.26 Bn 2.41 Bn
2 AbbVie 462.60 Bn 435.75 Bn 12.70 Bn 1.77 Bn
3 Merck 358.70 Bn 313.13 Bn 12.21 Bn 2.47 Bn
4 Novartis Ag 272.16 Bn 228.03 Bn 11.24 Bn 1.94 Bn
5 Astrazeneca 250.36 Bn 223.92 Bn 12.86 Bn 1.55 Bn
6 Amgen 227.87 Bn 183.27 Bn 7.24 Bn 540.00 Mn
7 Gilead Sciences 184.97 Bn 159.08 Bn 6.22 Bn 1.24 Bn
8 Pfizer 162.61 Bn 109.56 Bn 10.94 Bn 5.70 Bn
9 Vertex Pharmaceuticals 132.45 Bn 104.46 Bn 2.84 Bn 253.70 Mn
10 Denali Therapeutics 3.30 Bn 3.30 Bn 3.51 Mn 187.31 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 187.31 Mn
Mar 31, 2026 186.64 Mn
Dec 31, 2025 172.65 Mn
Sep 30, 2025 172.42 Mn
Jun 30, 2025 171.45 Mn
Mar 31, 2025 171.22 Mn
Dec 31, 2024 164.47 Mn
Sep 30, 2024 169.46 Mn
Jun 30, 2024 168.83 Mn
Mar 31, 2024 149.40 Mn
Dec 31, 2023 137.37 Mn
Sep 30, 2023 137.64 Mn
Jun 30, 2023 137.05 Mn
Mar 31, 2023 136.52 Mn
Dec 31, 2022 125.53 Mn
Sep 30, 2022 123.47 Mn
Jun 30, 2022 123.01 Mn
Mar 31, 2022 122.67 Mn
Dec 31, 2021 121.52 Mn
Sep 30, 2021 121.74 Mn
API Access

Denali Therapeutics Shares Outstanding API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=shares-outstanding&ticker=DNLI&period=max&api_key=YOUR_API_KEY